Addington, D., Addington, J. & Patten, S. (1996) Gender and affect in schizophrenia. Canadian Journal of Psychiatry, 41, 265–268.
American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM–IV). Washington, DC: APA.
Cheadle, A. J., Freeman, H. L. & Korer, J. (1978) Chronic schizophrenic patients in the community. British Journal of Psychiatry, 133, 221–227.
Cooper, S. J., Kelly, C. B. & McClelland, R. J. (1995) Affective disorders: 3. Electroconvulsive therapy. In Seminars in Clinical Psychopharmacology (ed. King, D. J.) pp. 224–258. London: Gaskell.
De Alarcon, R. & Carney, M. W. P. (1969) Severe depressive mood changes following slow-release intra-muscular fluphenazine injection. British Medical Journal, iii, 564–567.
Drake, R. E. & Ehrlich, J. (1985) Suicide attempts associated with akathisia. American Journal of Psychiatry, 142, 499–501.
Drake, R. E. & Cotton, P. G. (1986) Depression, hopelessness and suicide in chronic schizophrenia. British Journal of Psychiatry, 148, 554–559.
Falloon, I., Watt, D. C. & Shepherd, M. (1978) A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia. Psychological Medicine, 8, 59–70.
Glazer, W., Prusoff, B., John, K.
et al (1981) Depression and social adjustment among chronic schizophrenic outpatients. Journal of Nervous and Mental Disease, 169, 712–717.
Herz, M. & Melville, C. (1980) Relapse in schizophrenia. American Journal of Psychiatry, 137, 801–805.
Hirsch, S. R., Gaind, R., Rohde, P. D.
et al (1973) Outpatient maintenance of chronic schizophrenic patients with long-term fluphenazine: double-blind placebo trial. British Medical Journal, i, 633–637.
Hirsch, S. R., Jolley, A. G., Barnes, T. R. E.
et al (1989) Dysphoric and depressive symptoms in chronic schizophrenia. Schizophrenia Research, 2, 259–264.
Johnson, D. A. W. (1981a) Studies of depressive symptoms in schizophrenia: I. The prevalence of depression and its possible causes; II. A two-year longitudinal study of symptoms; III. A double-blind trial of orphenadrine against placebo; IV. A double-blind trial of nortriptyline for depression in chronic schizophrenia. British Journal of Psychiatry, 139, 89–101.
Johnson, D. A. W. (1981b) Depressions in schizophrenia: Some observations on prevalence, aetiology and treatment. Acta Psychiatrica Scandinavica, 63 (suppl 291), 137–144.
Johnson, D. A. W., Pasterski, G., Ludlow, J.
et al (1983) The discontinuance of maintenance neuroleptic therapy in chronic schizophrenic patients: drug and social consequences. Acta Psychiatrica Scandinavica, 67, 339–352.
Johnstone, E. C., Owens, D. G. C., Gold, A.
et al (1984) Schizophrenic patients discharged from hospital: a follow-up study. British Journal of Psychiatry, 145, 586–590.
King, D. J., Burke, M. & Lucas, R. A. (1995) Antipsychotic drug-induced dysphoria. British Journal of Psychiatry, 167, 480–482.
Kingdon, D., Turkington, D. & John, C. (1994) Cognitive behaviour therapy of schizophrenia. The amenability of delusions and halucinations to reasoning. British Journal of Psychiatry, 164, 581–587.
Knights, A. & Hirsch, S. R. (1981) ‘Revealed’ depression and drug treatment for schizophrenia. Archives of General Psychiatry, 38, 806–811.
Kohler, C., Gur, R. C. & Swanson, C. L. (1998a) Depression in schizophrenia: I. Association with neuropsychological deficits. Biological Psychiatry, 43, 165–172.
Kohler, C., Swanson, C. L. & Gur, R. C. (1998b) Depression in schizophrenia: II. MRI and PET findings. Biological Psychiatry, 43, 173–180.
Leff, J. (1990) Depressive symptoms in the course of schizophrenia. In Depression in Schizophrenia (ed. DeLisi, L. E.) Washington, DC: American Psychiatric Press.
Meltzer, H. Y. & Okalyi, G. (1995) Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk assessment. American Journal of Psychiatry, 152, 183–190.
Mulholland, C., Lynch, G., Cooper, S. J.
et al (1997) A double-blind, placebo-controlled trial of sertraline for depressive symptoms in stable, chronic schizophrenia (abstract). Biological Psychiatry, 42, 15.
Pogue-Geile, M. (1989) Negative symptoms and depression in schizophrenia. In Depression in Schizophrenics (eds Williams, R. & Dalby, J. T.) pp. 121–130. New York: Plenum.
Plasky, P. (1991) Antidepressant usage in schizophrenia. Schizophrenia Bulletin, 17, 649–657.
Prasad, A. J. (1986) Attempted suicide in hospitalised schizophrenics. Acta Psychiatrica Scandinavica, 74, 41–42.
Roy, A., Thompson, R. & Kennedy, S. (1983) Depression in chronic schizophrenia. British Journal of Psychiatry, 142, 465–470.
Siris, S. G. (1990) Depressive symptoms in the course of schizophrenia. In Depression in Schizophrenia (ed. DeLisi, L. E.) pp. 3–23. Washington, DC: American Psychiatric Press.
Siris, S. G. (1994) Assessment and treatment of depression in schizophrenia. Psychiatric Annals, 24, 463–467.
Subotnik, K. L., Nuechterlein, K. H., Asarnow, R. F.
et al (1997) Depressive symptoms in the early course of schizophrenia: relationship to familial psychiatric illness. American Journal of Psychiatry, 154, 1551–1556.
Tollefson, G. D., Beasley, C. M., Tran, P. V.
et al (1997) Olanzapine and haloperidol in the treatment of schizophrenia, schizoaffective and schizophreniform disorders: results of an international collaborative trial. American Journal of Psychiatry, 154, 457–465.
Van Putten, T., May, P. R. A. (1978) Akinetic depression in schizophrenia. Archives of General Psychiatry, 35, 1101–1107.
World Health Organization (1992) The ICD–10 Classification of Mental and Behavioural Disorders. Clinical Description and Diagnostic Guidelines. Geneva: WHO.